AUTL · Autolus Therapeutics plc · Held by Funds
Market Cap
$493.73M
Shares
266.16M
Volume · Sep 30
1.16M
Avg daily vol (3M)
2.04M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding AUTL
12 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| iShares Biotechnology ETF | IBB | 1,428,929 | $2,286,286 | 0.03% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 120,878 | $226,042 | 0.00% | Long | 2026-05-31 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | GWX | 84,409 | $135,054 | 0.02% | Long | 2026-06-30 | |
| PMC Diversified Equity Fund | — | 18,516 | $111,096 | 0.02% | Long | 2024-02-29 | |
| Invesco NASDAQ Future Gen 200 ETF | QQQS | 44,936 | $84,030 | 0.44% | Long | 2026-05-31 | |
| Range Cancer Therapeutics ETF | CNCR | 39,347 | $68,070 | 0.76% | Long | 2025-02-28 | |
| ActivePassive International Equity ETF | APIE | 22,753 | $42,548 | 0.00% | Long | 2026-05-31 | |
| Invesco Nasdaq Biotechnology ETF | IBBQ | 10,575 | $19,775 | 0.03% | Long | 2026-05-31 | |
| ProShares Ultra Nasdaq Biotechnology | BIB | 7,414 | $13,864 | 0.02% | Long | 2026-05-31 | |
| Defiance Nasdaq Junior Biotechnology ETF | — | 1,305 | $8,548 | 0.12% | Long | 2021-09-30 | |
| ProShares UltraPro Nasdaq Biotechnology | — | 610 | $4,990 | 0.02% | Long | 2020-02-29 | |
| Blackstone Alternative Multi-Strategy Fund | — | 14,000 | $22,400 | 0.00% | Short | 2026-06-30 |
Showing 1–12 of 12 positions